Linder et al. [61] found that deletion or inhibition of EGFR directly inhibited the proliferation of osteosarcoma cells by constructing autologous c-Fos-dependent OS mouse and human biopsy samples for preclinical studies. The gene discussed is FOS; the disease is osteosarcoma.